News
Presenting results from the REDEFINE 1 and REDEFINE 2 studies at the American Diabetes Association (ADA) congress in Chicago, ...
Danish pharma giant Novo Nordisk stock dipped more than 2.5% in early trade on Monday as market watchers reacted to promising data from rival Eli Lilly (LLY) as it tests an experimental weight loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results